Birinapant: Preliminary Phase IIa data

Preliminary data from 9 azacitidine-naive patients with higher risk MDS in a double-blind, placebo-controlled, international Phase IIa trial showed that twice-weekly 13 mg/m 2 IV birinapant for 3 week...